Apollomics Inc. (APLM) appoints Hung-Hsien Yen to board
Rhea-AI Filing Summary
Apollomics Inc. reported changes to its Board of Directors effective July 20, 2026. Directors Yi-An Chu and Dr. Chen-Huan (Jack) Jan resigned, and the company states these resignations were not related to any disagreement. The Board appointed Hung-Hsien Yen as a Class I director to fill the vacancy. He will also serve on the Audit Committee and as Chairman of the Nominating and Corporate Governance Committee.
Following these changes, the Board has six members, including four independent directors. Hung-Hsien Yen brings over 25 years of experience in private equity and direct investments and currently chairs SINO SUN CAPITAL INVESTMENT CO., LTD. His compensation includes 500 restricted stock units vesting on September 15, 2026, an annual cash retainer of $24,000, plus $5,000 for Audit Committee service and $10,000 for chairing the Nominating and Corporate Governance Committee. This information is incorporated by reference into Apollomics’ Form S-8 and Form F-3 registration statements.
Positive
- None.
Negative
- None.
Key Figures
Board size: 6 directors
Independent directors: 4 directors
RSU grant: 500 restricted stock units
+5 more
8 metrics
Board size
6 directors
Total Board members following changes effective July 20, 2026
Independent directors
4 directors
Independent Board members after appointment of Hung-Hsien Yen
RSU grant
500 restricted stock units
Equity award to Hung-Hsien Yen, vesting on September 15, 2026
Annual base retainer
$24,000
Cash compensation to Hung-Hsien Yen as director, payable $2,000 per month
Audit Committee fee
$5,000
Annual fee for Hung-Hsien Yen’s service as Audit Committee member
Committee chair fee
$10,000
Annual fee for Hung-Hsien Yen as Chairman of Nominating and Corporate Governance Committee
Experience
over 25 years
Hung-Hsien Yen’s experience in private equity and direct investments
RSU vesting date
September 15, 2026
Vesting date for the 500 restricted stock units granted to Hung-Hsien Yen
Key Terms
restricted stock units, independent directors, Audit Committee, Nominating and Corporate Governance Committee, +2 more
6 terms
restricted stock units financial
"a pro-rated annual equity award consisting of 500 restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
independent directors regulatory
"Dr. Hong-Jung (Moses) Chen, Hsien-Shu (Jerry) Tsai, Dr. Ya-Chi (Claudia) Huang, and Hung-Hsien Yen are independent directors"
Members of a company’s board who do not have significant business, family, or financial ties to the company and are not part of its management; they are chosen to provide impartial oversight of strategy, financial reporting, executive pay and risk. They matter to investors because independent directors act like an objective referee, helping ensure decisions favor shareholders’ long-term interests rather than insiders, which can strengthen trust and reduce the chance of mismanagement or conflicts of interest.
Audit Committee regulatory
"Mr. Hung-Hsien Yen will also serve as a member of the Company’s Audit Committee"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
Nominating and Corporate Governance Committee regulatory
"Chairman of the Nominating and Corporate Governance Committee"
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
registration statements on Form S-8 regulatory
"including its registration statements on Form S-8"
Form F-3 regulatory
"and Form F-3 (File Nos. 333-278430, 333-278431, 333-279549, and 333-294154)"
Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What board changes did Apollomics (APLM) disclose for July 2026?
Apollomics reported that Yi-An Chu and Dr. Chen-Huan (Jack) Jan resigned from its Board on July 20, 2026, and Hung-Hsien Yen was appointed as a Class I director, joining the Audit Committee and chairing the Nominating and Corporate Governance Committee.
Who is Hung-Hsien Yen, the new director at Apollomics (APLM)?
Hung-Hsien Yen is a seasoned investment professional with over 25 years of experience in private equity and direct investments. He serves as Chairman of SINO SUN CAPITAL INVESTMENT CO., LTD. and as an independent director of STL Technology Co., Ltd. and KOJEM INTERNATIONAL CO., LTD.
How is new director Hung-Hsien Yen compensated by Apollomics (APLM)?
Hung-Hsien Yen receives a pro-rated equity award of 500 restricted stock units, vesting on September 15, 2026, plus an annual cash retainer of $24,000, an additional $5,000 for Audit Committee service, and $10,000 for chairing the Nominating and Corporate Governance Committee.
How many independent directors does Apollomics (APLM) now have?
After the July 2026 changes, Apollomics’ Board has six members in total, of whom four—Dr. Hong-Jung (Moses) Chen, Hsien-Shu (Jerry) Tsai, Dr. Ya-Chi (Claudia) Huang, and Hung-Hsien Yen—are identified as independent directors.
Were Apollomics (APLM) director resignations tied to a disagreement?
The company states that the July 20, 2026 resignations of Yi-An Chu and Dr. Chen-Huan (Jack) Jan from the Board were not related to any disagreement with Apollomics, indicating no reported dispute behind their departures.
How does this Apollomics (APLM) 6-K relate to its registration statements?
The information is incorporated by reference into Apollomics’ registration statements under the Securities Act, including its Form S-8 and Form F-3 filings, becoming part of those registration statements unless later superseded by other reports.